The Asian Pacific Association for the Study of the Liver

2017年09月01日

去る2017年4月10日に、肝疾患の国際学会である”The Asian Pacific Association for the Study of the Liver, Single Topic Conference 2017 Nagasaki”に参加しました。当教室からも4演題発表し、活発なディスカッションを行ってきました。

Survival benefit of liver resection for hepatocellular carcinoma with hepatic vascular invasion Yasuhiro Nakayama, Minoru Sakamoto, Natsuko Nakakuki, Shuya Matsuda, Masaru Muraoka, Yuuichirou Suzuki, Mitsuaki Satou, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto
The incidence of hepatocellular carcinoma after daclatasvir plus asunaprevir therapy in HCV-1b Hepatitis who achieved sustained virologic response Mitsuaki Sato, Shinya Maekawa, Natsuko Nakakuki, Shuya Matsuda, Masaru Muraoka, Yuichiro Suzuki, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Nobuyuki Enomoto
Liver dysfunction caused by daclatasvir and asunaprevir combination therapy-its influence on the SVR rate and the association with the drug-metabolizing enzyme polymorphisms. Natsuhiko Kuratomi, shinya Maekawa, Natsuko Nakakuki, Shuya Matsuda, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Yasuhiro Nakayama, Minoru Sakamoto, Nobuyuki Enomoto
The value of using HBsAg and HBcrAg in combination for the assessment of HCC risk. Yuichiro Suzuki, shinya Maekawa, Natsuko Nakakuki, Shuya Matsuda, Masaru Muraoka, Mitsuaki Sato, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Nobuyuki Enomoto